Skip to main content

Table 3 Mean values of thrombocytes, leucocytes, GOT, GPT, TSH and albumin at the following time points: before cCRT; before Durvalumab; at 3-, 6-, 9- and 12-month follow-up. We also calculated weight changes as a percentage of baseline at each time point

From: Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

  Reference value Baseline Start Durvalumab 3-month follow-up 6-month follow-up 9-month follow-up 12-month follow-up
Thrombocytes [G/l] 176–391 286.91 247.68 254.41 267.00 252.70 279.63
Leukocytes [G/l] 4–10.4 7.70 5.83 6.35 6.81 6.81 7.30
GOT [U/l] >  49 25.82 26.59 27.95 27.79 27.16 30.17
GPT [U/l] >  49 27.64 28.64 28.50 29.84 31.26 36.56
TSH [μU/ml] 0.27–4.2 1.35 1.34 1.64 3.09 1.86 2.05
Albumin [g/dl] 3,5 - 5,2 4.01 4.09 4.10 4.25 4.18 4.20
Weight change [%] - 2 0 + 2 + 4 + 3